Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...

In addition to the IND approval, Cartography Bio also announced that CBI-1214 has been granted Fast Track designation by the FDA. This status is designed to facilitate the development and expedited ...

As people age, their immune system function declines. T cell populations become smaller and can't react to pathogens as ...

Yarrow's Graves' disease pick Finally, this week – so far at least – Yarrow Bioscience has paid $70 million upfront for ex-China rights to an antibody targeting the thyroid-stimulating hormone ...

Immune protection fades with time, and much of that decline traces back to the thymus. This small organ, located in front of the heart, trains new T cells and releases signals that help them survive.

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation ...

One of the most lethal forms of breast cancer has long shrugged off the best drugs in the oncologist’s arsenal, leaving ...

Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), ...

BioNTech has completed its exchange offer to acquire CureVacAcquisition complements BioNTech’s capabilities and proprietary technologies in mRNA ...

Through the collaboration, Peptinovo and Chemelectiva developed and scaled a first-of-its-kind semi-synthetic vitamin E compound that is central to Peptinovo’s technology. The innovation enables ...

RNA vaccines, such as those used against COVID-19, are effective at generating antibody responses. These antibodies are ...

Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering targeted cancer therapies through its proprietary PALM™ nanotechnology, today announced a major manufacturing ...